40 likes | 46 Views
Global Wearable Injectors Market Insights<br>Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).<br>Wearable injectors are delivery methods that stick to the skin and allow for long-term subcutaneous drug administration. The equipment in wearable injectors gives more accurate dosing, along with other clinical advantages, and higher delivery precision. The components of any wearable injector are the same: a reservoir for medication
E N D
Global Wearable Injectors Market Size, Share, Growth Analysis, By Type by Therapy- Industry Forecast 2023-2030 Global Wearable Injectors Market Insights Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030). Wearable injectors are delivery methods that stick to the skin and allow for long-term subcutaneous drug administration. The equipment in wearable injectors gives more accurate dosing, along with other clinical advantages, and higher delivery precision. The components of any wearable injector are the same: a reservoir for medication, a cannula for tissue supply, an adhesion to secure the equipment to the skin's surface, and a driving mechanism to provide the right amount of medication. Comparing wearable injectors to traditional injecting techniques, they are a more affordable form of administration. The market for wearable injectors is expected to develop as a result of the advantages these devices have over
traditional injections, including better drug dose and time control, enhanced patient ease and satisfaction, and a decrease in methodological problems. But throughout the projected timeline, unfavorable reimbursement rules are expected to slow the rising demand for wearable injectors. Global Wearable Injectors Market Segmental Analysis The global wearable injectors market segmentation is based on type, therapy, and region. Based on type the market is segmented into on-body and off-body. Based on therapy the market is segmented into diabetes, cardiovascular disease, immuno-oncology, and others. Based on region the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Wearable Injectors Market Analysis by Type In 2021, the on-body market category held the highest market share. Particularly on the stomach, these feel comfortable against the body. In- home care settings can also utilize them easily because they are waterproof. Additionally, it is predicted that the segment would develop faster in the years to come due to an increase in the market for home care. However, the prediction predicts that off-body injectors will increase the most in the coming few years. Off-body injectors have gained popularity as a result of the drawbacks of on-body injectors, such as unpleasant withdrawal, contact dermatitis and irritation, and problems with adhesive compatibility. Get the best overview of Wearable Injectors Market https://www.skyquestt.com/report/wearable-injectors-market
Top Players in the Global Wearable Injector Market •Ypsomed •Amgen •Subcuject (Denmark) •Becton, Dickinson and Company (BD) •Bespak Europe Ltd. •CeQur SA •Debiotech SA •Enable Injections •Insulet Corporation •Medtronic plc •Mylan N.V. •Nemera Development S.A. •Omron Corporation •Pfizer Inc. •Roche Holding AG •Sensile Medical AG •SteadyMed Therapeutics, Inc. •Tandem Diabetes Care, Inc. •United Therapeutics Corporation •West Pharmaceutical Services, Inc. •Zosano Pharma Corporation About Us: Sky Quest Technology is leading growth consulting firm providing market intelligence, commercialization, and technology services. It has 450+ happy clients globally. Address:
1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email:sales@skyquestt.com Sky Quest